Philipp Knechtle / Selmod

Biotech, Uni Basel

Development of innovative small molecule therapies for the treatment of life-threatening invasive fungal infections, which represent around 2 million new cases every year worldwide.

http://www.venturelab.ch/selmod

Selmod